| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |